| Financial Year |
March 31 2022 |
| Monetary Funds |
2,057,114,830.03 |
| Held-for-trading Financial Assets |
44,054.44 |
| Notes Receivable |
-- |
| Accounts Receivable |
42,674,598.54 |
| Advances to Suppliers |
246,543,827.84 |
| Other Receivables |
13,851,635.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,173,321,287.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
403,316,703.32 |
| Total Current Assets |
6,348,651,978.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,062,741,296.74 |
| Investment Properties |
-- |
| Fixed Assetes |
10,246,448,332.12 |
| Under-construction Projects |
2,256,959,688.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
331,363,701.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
11,891,026.62 |
| Other Non-Current Assets |
1,321,227,527.54 |
| Sub-Total of Non-Current Assets |
15,560,854,018.82 |
| Total Assets |
21,909,505,997.32 |
| Short-Term Loans |
1,171,079,335.96 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,848,777,314.15 |
| Accounts Payable |
3,702,212,523.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
45,478,733.21 |
| Taxes Payable |
15,318,962.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
274,328,214.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
28,965,862.75 |
| Other Current Liabilities |
133,774,388.42 |
| Sub-Total of Current Liabilities |
9,253,547,590.26 |
| Long-term Loans |
1,011,001,611.21 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,210,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,580,808,130.31 |
| Total Liabilities |
10,834,355,720.57 |
| Paid-In Capital(Or Share Stock) |
2,423,474,890.00 |
| Capital Surplus |
3,190,442,929.86 |
| Surplus Reserve |
1,163,873,556.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,308,109,171.06 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,075,150,276.75 |
| Owner's Equity（Stockholder's Equity） |
11,075,150,276.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,909,505,997.32 |
